EASL Clinical Practice Guidelines: management of chronic hepatitis B.
about
Continued lamivudine for adults with lamivudine-resistant chronic hepatitis B virus infectionEntecavir for chronic hepatitis BLamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantationInterferon alpha for chronic hepatitis BSophorus species for chronic hepatitis B virus infectionInterferon beta for chronic hepatitis BInterferon gamma for chronic hepatitis BTelbivudine for chronic hepatitis BCurrent trends in management of hepatitis B virus reactivation in the biologic therapy eraKASL clinical practice guidelines: management of chronic hepatitis BEfficacy of Tenofovir-Based Combination Therapy versus Tenofovir Monotherapy in Chronic Hepatitis B Patients Presenting with Suboptimal Responses to Pretreatment: A Meta-AnalysisHepatocellular carcinoma and hepatitis B surface proteinControversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinomaHepatitis B and Delta Virus: Advances on Studies about Interactions between the Two Viruses and the Infected HepatocyteHepatitis B virus reactivation with a rituximab-containing regimenHepatitis B and C virus reactivation in immunosuppressed patients with inflammatory bowel diseaseTumor necrosis factor-α inhibitors and chronic hepatitis C: a comprehensive literature reviewHepatitis B virus reactivation with rituximab-containing regimenApplication of nucleoside analogues to liver transplant recipients with hepatitis BΜanagement of patients with hepatitis B and C before and after liver and kidney transplantationOccult hepatitis B virus infectionClinical impact of occult hepatitis B virus infection in immunosuppressed patientsManagement of chronic hepatitis B before and after liver transplantationManagement of chronic hepatitis B in pregnancyNew virologic tools for management of chronic hepatitis B and CNucleoside/nucleotide analogues in the treatment of chronic hepatitis BAntiviral Therapy in Lamivudine-Resistant Chronic Hepatitis B Patients: A Systematic Review and Network Meta-AnalysisLiver stiffness measurement and biochemical markers in Senegalese chronic hepatitis B patients with normal ALT and high viral loadUltra-deep pyrosequencing detects conserved genomic sites and quantifies linkage of drug-resistant amino acid changes in the hepatitis B virus genomeComparison of efficacy and safety of tenofovir and entecavir in chronic hepatitis B virus infection: a systematic review and meta-analysisCost-Effectiveness and Cost Thresholds of Generic and Brand Drugs in a National Chronic Hepatitis B Treatment Program in ChinaSafety and efficacy of telbivudine for the treatment of chronic hepatitis BRelationship between level of hepatitis B virus DNA and liver disease: a population-based study of hepatitis B e antigen-negative persons with hepatitis B.Factors associated with significant liver necroinflammation in chronic hepatitis B patients with cirrhosisAsian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Real-time elastography as a noninvasive technique for quantification of fibrosis in patients with chronic viral liver disease: Preliminary findings.Two classifiers based on serum peptide pattern for prediction of HBV-induced liver cirrhosis using MALDI-TOF MS.Detection of focal liver lesions in cirrhotic liver using contrast-enhanced ultrasound.The use of individual patient-level data (IPD) to quantify the impact of pretreatment predictors of response to treatment in chronic hepatitis B patients.Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association.
P2860
Q24185958-245EB2D0-F4D8-47EB-90EC-BCB6661E8A33Q24194997-9BE39024-AC8C-4040-8CBB-D8F6316DA808Q24234338-B17B8111-40F8-4857-A850-8783D5AC72F4Q24235232-8862E3C2-4016-4B25-BD03-4D56FE7F0AA3Q24235441-21F39D52-7982-4F46-AAD0-28F321844289Q24235548-E15B39A8-A517-4ECC-B270-9075855929DEQ24235598-D19102FA-00F8-48CB-A7AF-0D6A7B5EA376Q24235644-ED7AB12F-415B-439D-94FA-35144E749E77Q24634879-066E4861-B8FB-433F-B332-782F4CD31C7CQ26752475-AE2A11BE-103F-4EF1-825B-4C9936712138Q26765932-278516C1-DE46-4402-ADE0-82264C3CA5DAQ26766123-6A295917-171E-4794-BD6F-EDA3F83CBCE6Q26772324-B7052BDD-41C3-4EAD-832C-A9F82E40FB31Q26775635-DBC58379-924B-4B05-8C80-201F4F820730Q26785963-676D93A2-6130-4546-98A8-8469A1E33887Q26827444-C6A7BD7F-932E-45EC-A2CE-BCC9DB3F78CFQ26829390-39B9BC7C-9575-42E9-919C-F619E839533AQ26830484-F0730078-8934-40A5-8003-96FC6C747BF4Q26859796-A6E779C9-A348-4E69-8BE3-9EF45A7572F2Q26864647-091CFF34-05AC-42DA-A3E7-733CA91CC5EDQ27004224-48B9933A-181D-4EE7-8199-F45E34C399EEQ27006996-8473EB3D-DA8B-4531-9B48-F5D61B483087Q27024831-9F36E8B6-A972-405C-BA25-64A7FDB3545EQ27026593-D0995B93-A96D-4C16-9B3A-6F1177AFD33BQ27026914-B0C8DE95-ACF2-4638-A1BF-48059FC72D19Q27030828-0D7742A7-DE40-482C-9AA1-8E9EEE12DBC3Q28074579-43F48BF2-F24A-4CDF-990E-5A535763802DQ28479262-82049123-6F67-4948-A2C5-65F121B6B009Q28484005-DBF24377-D0DA-4D14-81E2-1D200EAE578AQ28539472-0CDE1B8C-EEF2-44F3-8B5C-0CD89C00A209Q28550643-83A46376-5DC9-4B3A-9AEB-27511C82EC43Q28972486-CDD3950C-01FB-4770-BC2D-6FE578EE8117Q30220690-A4BB5FDA-FF4D-4A54-9FF9-80951285084CQ30374334-B02A2014-2E75-4D2F-991F-2F6040406C67Q30391932-701C6000-B696-4765-8417-26FC4141CE9BQ30454108-14E5C569-F21D-4733-BA2F-8DB945FB5A74Q30456214-BA4E36E6-E5EF-4A53-AB1A-D3AAD33F7D3AQ30478166-6447C547-3F96-49C8-BAC2-ECB02EFA46A4Q30586377-57C7C8A0-3833-4D36-8B02-A31478674700Q30634658-81D63123-2303-4454-850D-C2F3E3B20F3E
P2860
EASL Clinical Practice Guidelines: management of chronic hepatitis B.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
EASL Clinical Practice Guidelines: management of chronic hepatitis B.
@en
EASL Clinical Practice Guidelines: management of chronic hepatitis B.
@nl
type
label
EASL Clinical Practice Guidelines: management of chronic hepatitis B.
@en
EASL Clinical Practice Guidelines: management of chronic hepatitis B.
@nl
prefLabel
EASL Clinical Practice Guidelines: management of chronic hepatitis B.
@en
EASL Clinical Practice Guidelines: management of chronic hepatitis B.
@nl
P1476
EASL Clinical Practice Guidelines: management of chronic hepatitis B.
@en
P2093
European Association For The Study Of The Liver
P304
P356
10.1016/J.JHEP.2008.10.001
P577
2008-10-29T00:00:00Z